A formulator and manufacturer of adhesives, sealants, and specialty chemicals, H.B. Fuller's products hold together everything from packaged goods and diapers to cars, electronics, and aircraft. It began in 1887 in St. Paul, Minnesota, when Harvey Benjamin Fuller started selling flour-and-water paste and his 'Premium Liquid Fish Glue,' famously marketed to 'cement everything' from tin cans to factory barrels. He even invented adjustable scaffolding for safer wallpaper hanging.
On July 17, 2026, H.B. Fuller entered into Amendment No. 3 to its Second Amended and Restated Credit Agreement with JPMorgan Chase Bank as administrative agent.
Show detailsHide details
The amendment refinanced $420 million of term A loans and $700 million of revolving loans, and increased revolving commitments by $100 million to $800 million total.
Maturity of the amended term A and revolving loans was extended to July 17, 2031, and interest rate margins were reduced by 25 basis points.
The Secured Bridge Credit Agreement dated June 25, 2026 was terminated with no loans outstanding and no prepayment premium.
The amendment is filed as Exhibit 10.1 to the Form 8-K.
1.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits
H.B. Fuller agrees to acquire Advanced Medical Solutions for 285 pence per share in cash
The transaction will be implemented via a court-sanctioned scheme of arrangement under the UK Companies Act, with completion expected by the end of calendar year 2026.
Show detailsHide details
H.B. Fuller's wholly-owned subsidiary Bidco will acquire all of Advanced Medical Solutions Group plc (AMS) for 285 pence in cash per AMS share.
The offer is subject to AMS shareholder approval (75% in value), court sanction, regulatory approvals, and effectiveness by June 25, 2027.
H.B. Fuller secured bridge financing: a $2.087 billion secured bridge credit agreement and a $917 million unsecured bridge credit agreement, both with Goldman Sachs Bank USA as administrative agent.
AMS board members holding shares have given irrevocable undertakings to vote in favor, representing approximately 0.34% of AMS's outstanding shares.
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
H.B. Fuller shareholders elect three directors, ratify Ernst & Young, and approve executive compensation at 2026 annual meeting.
Daniel L. Florness, Celine C. Martin, and Teresa J. Rasmussen were each elected to three-year terms as directors, with votes for ranging from 47,640,273 to 49,746,246.
Show detailsHide details
H.B. Fuller held its 2026 Annual Meeting of Shareholders on April 16, 2026, with 51,790,961 shares represented, constituting a quorum.
Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending November 28, 2026, with 51,490,426 votes for.
A non-binding advisory vote to approve named executive officer compensation passed with 48,718,166 votes for, 1,227,485 against, and 122,041 abstentions.
The report was filed under Item 5.07 to disclose the results of these shareholder votes.
5.07 Submission of Matters to a Vote of Security Holders
H.B. Fuller elects Celine Martin to Board of Directors, effective December 1, 2025
Ms. Martin will serve on the Audit Committee and the Compensation Committee.
Show detailsHide details
On October 2, 2025, the Board of Directors elected Celine Martin, age 51, as a Class III director, effective December 1, 2025, with an initial term expiring at the 2026 annual meeting.
She most recently served as Company Group Chairman of the Cardiovascular & Specialty Solutions Group at Johnson & Johnson from 2022 to 2025.
As a director, she will receive an annual cash retainer of $100,000 and an initial grant of 1,300 restricted stock units, with eligibility for an annual discretionary grant of deferred phantom stock units valued at $165,000.
Effective December 1, 2025, the board will have nine directors, eight of whom are independent.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits